Dec 12, 2022 | Jack Aiello
Today’s oral presentations examined prognostic factors for newly diagnosed multiple myeloma patients, new drugs, and optimized treatment approaches, as well as prognostic markers. I’ll show some of the abstract results below from those sessions. We also met with...
Dec 11, 2022 | Linda Huguelet
On Saturday, our team had the distinct privilege to attend the International Myeloma Working Group (IMWG) meeting. This organization includes over 280 myeloma specialists and researchers from all over the world who share the same goal of advancing myeloma research...
